Collagen type XVI expression is modulated by basic fibroblast growth factor and transforming growth factor-beta

Area of Science:

• Cell biology
• Biochemistry
• Extracellular matrix research

Background:

• Type XVI collagen is a fibril-associated collagen.
• Human dermal fibroblasts and arterial smooth muscle cells produce type XVI collagen.
• Fibroblast growth factor (FGF) and transforming growth factor-beta (TGF-beta) are key regulators of cellular processes.

Purpose of the Study:

• To investigate the effects of bFGF and TGF-beta on type XVI collagen expression.
• To determine how these growth factors influence collagen mRNA and protein levels.
• To compare the regulatory mechanisms of type XVI collagen with major fibrillar collagens.

Main Methods:

• Quantitative analysis of alpha1(XVI) collagen mRNA levels.
• Immunoprecipitation of metabolically labeled human dermal fibroblasts and arterial smooth muscle cells.
• Assessment of protein expression changes in response to growth factor treatment.

Main Results:

• bFGF significantly decreased alpha1(XVI) collagen mRNA expression (18-24% of controls).
• TGF-beta significantly increased alpha1(XVI) collagen mRNA expression (150-360% of controls).
• Corresponding, though less pronounced, changes were observed at the protein level for type XVI collagen.

Conclusions:

• Type XVI collagen expression is differentially regulated by bFGF and TGF-beta.
• The regulation of type XVI collagen by these growth factors mirrors that of major type I fibrillar collagen.
• These findings provide insights into the control of extracellular matrix composition by specific growth factors.